0001179110-18-008933.txt : 20180622 0001179110-18-008933.hdr.sgml : 20180622 20180622140701 ACCESSION NUMBER: 0001179110-18-008933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180620 FILED AS OF DATE: 20180622 DATE AS OF CHANGE: 20180622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCCLUSKI STEPHEN C CENTRAL INDEX KEY: 0001188728 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 18914185 MAIL ADDRESS: STREET 1: 80 ARKAY DRIVE CITY: HAUPPAUGE STATE: NY ZIP: 11788 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 4 1 edgar.xml FORM 4 - X0306 4 2018-06-20 0 0000855654 IMMUNOGEN INC IMGN 0001188728 MCCLUSKI STEPHEN C 10 GRANDHILL WAY PITTSFORD NY 14534 1 0 0 0 Deferred Share Unit 0 2018-06-20 4 A 0 4000 0 A 2018-09-01 Common Stock 4000 54458 D Stock Option (right to buy) 11.21 2018-06-20 4 A 0 18000 11.21 A 2018-09-01 2028-06-20 Common Stock 18000 18000 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest quarterly on 9/1/18, 12/1/18, 3/1/19 and 6/1/19, contingent upon the individual remaining a director as of each vesting date. Exercisable as to 4,500 shares on 9/1/18, 12/1/18, 3/1/19 and 6/1/19, contingent upon the individual remaining a director as of each vesting date. /s/ Craig Barrows, attorney in fact 2018-06-22